BIO
Director Trades
| Date | Director | Value |
|---|---|---|
| 26/11/24 | D. Fisher | $26,387 |
| 26/11/24 | B. Norfolk | $59,571 |
| 27/11/24 | I. Faenza | $10,226 |
| 28/11/24 | G. Sam | $49,975 |
| 27/2/25 | G. Sam | $24,980 |
| 6/4/25 | G. Sam | $24,985 |
Company News
Biome Australia Expands Retail Distribution with Mecca and Go Vita Partnerships
Biome Australia (ASX: BIO) has struck new distribution agreements with Mecca and Go Vita, marking a significant expansion for its flagship Activated Probiotics range into both premium beauty and mainstream health food retail. The company said the partnerships represent a turning point in its distribution strategy, extending reach into high-traffic retail environments while reinforcing its […]
Market wrap: Australia ignores Wall Street record on faltering miners
The Australian share market once again ignored a rally on Wall Street to a fresh record high and closed down 0.3% thanks to a broad-based slump on Friday. It was yet another reminder of how the Australian bourse with its heavy concentration of miners and banks has disconnected from the Artificial Intelligence rally that is […]
Biome Australia expects to surpass FY24 earnings guidance on back of record sales revenue
Biome Australia (ASX: BIO) is on target to easily beat its 2024 financial year forecast after a strong period of revenue. The microbiome health specialist had predicted FY2024 earnings of $12.5 million but record sales numbers for April and May have increased expectations. This follows the company’s initial $11.5m estimate announced in October 2023 being […]
Market wrap: ASX 200 dips slightly despite energy rally
Despite a continuing rally for energy stocks on the back of a rising oil price, the Australian share market fell a little lower, following a volatile day on Wall Street. The energy sector was up 0.5% following rising oil prices which spiked to US$79 a barrel after the US and UK launched airstrikes on Houthi […]
Biome Australia lifts FY24 revenue guidance to $12.5m
Specialist live biotherapeutics health company Biome Australia (ASX: BIO) has significantly increased its full year revenue guidance to $12.5 million, boosted by better-than-expected sales in recent months. The new target comes just months after Biome revealed it was forecast to achieve a significantly improved full year 2024 revenue of $11.5m. The new target represents 74% […]